- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 33/242 - GoldCompounds thereof
Patent holdings for IPC class A61K 33/242
Total number of patents in this class: 315
10-year publication summary
|
3
|
10
|
20
|
45
|
59
|
58
|
47
|
32
|
21
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shenzhen Profound View Pharmaceutical Technology Co., Ltd. | 19 |
13 |
| Nanobiotix | 116 |
8 |
| The Regents of the University of California | 20590 |
6 |
| The General Hospital Corporation | 4840 |
6 |
| Northwestern University | 3530 |
5 |
| University of Notre Dame du Lac | 600 |
5 |
| Shenzhen Profound-View Pharma Tech Co., Ltd | 13 |
5 |
| Arizona Board of Regents on behalf of Arizona State University | 2875 |
4 |
| Case Western Reserve University | 1878 |
4 |
| Medsenic | 9 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6615 |
3 |
| Board of Regents, The University of Texas System | 6065 |
3 |
| Clene Nanomedicine, Inc. | 34 |
3 |
| Universidad de Chile | 175 |
3 |
| Universiteit Antwerpen | 409 |
3 |
| Universiteit Gent | 1375 |
3 |
| University of Kentucky Research Foundation | 716 |
3 |
| Varian Medical Systems, Inc. | 901 |
3 |
| Seoul National University R&db Foundation | 4055 |
3 |
| Goldred Nanobiotech Co., Ltd. | 4 |
3 |
| Other owners | 225 |